Location: Home
  • search
  • go
  • Relate News
  • 4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...
  • 4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...
  • 4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...
  • 4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018
  • 4/10/2024Review of Class 1 New Drug R&D in China 2018-2023
  • 4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...
  • 4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023
  • 4/9/2024CEO Podcast: Hengrui's US Subsidiary's CEO, CMO On Chinese Pharma Goin...
  • 4/8/2024Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
  • 4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...
  • 4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules
  • 4/5/2024Ascletis Drops FXR Agonist ASC42 After Disappointing Phase II Results
  • 4/5/2024China Continues to Crackdown on Monopoly and Unfair Market Practices i...
  • 4/5/2024UB and 7th Affiliated Hospital of SYU Launch A Joint Clinical Research...
  • 4/5/2024Drug R&D and Product Registration News Digest April 2024 (1)
  • 4/5/2024Recent Official Changes and Executive Moves
  • 4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...
  • 4/4/2024Rohto and Mitsui to Buy TCM Company for $590M
  • 4/3/2024Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
  • 4/3/2024NMPA Issues Announcement on the Implementation of Electronic Drug Regi...
  • 4/3/2024NMPA Issues the Principles and Procedures for Exploratory Studies of D...
  • 4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...
  • 4/3/2024Chinese ADC Investment Boom in Question With China-U.S. R&D Relations ...
  • 4/2/2024NHC Holds the 2024 National Drug Administration Work Conference
  • 4/2/2024CDE Solicits Comments on the Pharmaceutical Self-Assessment Report for...
  • 4/2/2024Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
  • 4/2/2024Takeda's Drive: Elevating Chinese Clinical Trials and Global Health
  • 4/1/2024NMPA Announces Package Insert Revision of Metronidazole Injection and ...
  • 4/1/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...
  • 4/1/2024Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...
  • Page:83/790 Total number of articles:23678: [First][<<] [81] [82] [83] [84] [85] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group